Research map: Mild behavioral impairment-apathy and Alzheimer's disease plasma phosphorylated tau biomarker levels

Back to the article

Papers in this map

  1. The Neuropsychiatric Inventory · Jeffrey L. Cummings · 1994 · 7641 citations · Cited by this paper
  2. From mild cognitive impairment to moderate Alzheimer's disease: Associations between decision-making capacity and awareness · 2026 · Related
  3. Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup · Clifford R. Jack · 2024 · 2682 citations · Cited by this paper
  4. Projected lecanemab wastage from vial discard: Simulation based on Japanese interim post-marketing surveillance summary statistics · 2026 · Related
  5. 2024 Alzheimer's disease facts and figures · 2024 · 2481 citations · Cited by this paper
  6. Elevated ferritin expression in microglia and extracellular amyloid-β deposition are associated with reduced neurofibrillary degeneration in human isocortex, but not allocortex · 2026 · Related
  7. Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years · Heiko Braak · 2011 · 2316 citations · Cited by this paper
  8. Associations between higher-order executive planning and subjective cognitive decline in middle-aged individuals · 2026 · Related
  9. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts · Thomas K. Karikari · 2020 · 1415 citations · Cited by this paper
  10. Recruitment challenges and strategies for engaging the Peruvian population in the ReDLat Study · 2026 · Related
  11. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ 42 in humans · Anne M. Fagan · 2005 · 1261 citations · Cited by this paper
  12. Disease burden of Alzheimer's disease and other dementias in older adults · 2026 · Related
  13. Apathy: a neuropsychiatric syndrome · Robert S. Marin · 1991 · 1091 citations · Cited by this paper
  14. Performance of the participant self-rating version of the Quick Dementia Rating System in a racially diverse cohort of non-demented older adults · 2026 · Related
  15. Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment · Zahinoor Ismail · 2015 · 861 citations · Cited by this paper
  16. Precuneus amyloid-β deposition involving the association of irritability and cognitive decline: A multi-cohort longitudinal study · 2026 · Related
  17. The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials · Reisa Anne Sperling · 2014 · 747 citations · Cited by this paper
  18. Microglial immunometabolic reprogramming in Alzheimer's disease: From mitochondrial dysfunction and redox imbalance to NLRP3 inflammasome-driven neuroinflammation · 2026 · Related
  19. Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer’s disease Neurons · Ravi Rajmohan · 2016 · 703 citations · Cited by this paper
  20. Enhancing Alzheimer Disease Detection Using Neuropsychiatric Symptoms: The Role of Mild Behavioural Impairment in the Revised NIA-AA Research Framework · 2025 · Related
  21. A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease · the Dominantly Inherited Alzheimer Network · 2020 · 687 citations · Cited by this paper
  22. Differential diagnosis and classification of apathy · Robert S. Marin · 1990 · 627 citations · Cited by this paper
  23. The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations · Zahinoor Ismail · 2017 · 568 citations · Cited by this paper
  24. Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ pathology are detected · Marc Suárez‐Calvet · 2020 · 425 citations · Cited by this paper
  25. Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography · Sebastian Palmqvist · 2016 · 408 citations · Cited by this paper
  26. Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer’s disease · Niklas Mattsson · 2020 · 386 citations · Cited by this paper
  27. Longitudinal plasma p-tau217 is increased in early stages of Alzheimer’s disease · Niklas Mattsson · 2020 · 376 citations · Cited by this paper
  28. Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease · Eric McDade · 2018 · 330 citations · Cited by this paper
  29. Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography · Joseph Therriault · 2022 · 284 citations · Cited by this paper
  30. The Neuropsychiatric Inventory: Development and Applications · Jeffrey L. Cummings · 2020 · 267 citations · Cited by this paper
  31. Plasma phospho-tau217 for Alzheimer’s disease diagnosis in primary and secondary care using a fully automated platform · Sebastian Palmqvist · 2025 · 192 citations · Cited by this paper
  32. Diagnostic criteria for apathy in neurocognitive disorders · David S. Miller · 2021 · 187 citations · Cited by this paper
  33. Sex differences in dopamine release regulation in the striatum · Jennifer E. Zachry · 2020 · 178 citations · Cited by this paper
  34. Mild behavioral impairment and its relation to tau pathology in preclinical Alzheimer’s disease · Maurits Johansson · 2021 · 157 citations · Cited by this paper
  35. Sex differences in neuropsychiatric symptoms in Alzheimer’s disease dementia: a meta-analysis · Willem S. Eikelboom · 2022 · 151 citations · Cited by this paper
  36. Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort · Augusto J. Mendes · 2024 · 98 citations · Cited by this paper
  37. Mild behavioral impairment is associated with progression to Alzheimer's disease: A clinicopathological study · Myuri T. Ruthirakuhan · 2022 · 88 citations · Cited by this paper
  38. Optimizing detection of Alzheimer’s disease in mild cognitive impairment: a 4-year biomarker study of mild behavioral impairment in ADNI and MEMENTO · Zahinoor Ismail · 2023 · 84 citations · Cited by this paper
  39. Plasma p‐tau immunoassays in clinical research for Alzheimer's disease · Charlotte Elisabeth Teunissen · 2024 · 82 citations · Cited by this paper

Source: OpenAlex (CC0)